Covid-19 related concerns and outcomes from shielding in clinically extremely vulnerable adults and children with neuromuscular disease

L. Spurr (London, United Kingdom), R. Wakeman (London, United Kingdom), H. Tan (London, United Kingdom), M. Chatwin (London, United Kingdom), A. Simonds (London, United Kingdom)

Source: Virtual Congress 2021 – A multidisciplinary approach to pulmonary rehabilitation and management of chronic respiratory diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. Spurr (London, United Kingdom), R. Wakeman (London, United Kingdom), H. Tan (London, United Kingdom), M. Chatwin (London, United Kingdom), A. Simonds (London, United Kingdom). Covid-19 related concerns and outcomes from shielding in clinically extremely vulnerable adults and children with neuromuscular disease. 3903

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
No therapeutic disadvantage for girls with asthma related symptoms
Source: Annual Congress 2007 - Epidemiology of paediatric asthma: genes, environment and prognosis
Year: 2007


Patterns of healthcare utilisation for respiratory complications of adults with neuromuscular disease: a population study
Source: Eur Respir J, 52 (3) 1800754; 10.1183/13993003.00754-2018
Year: 2018



No identifiable risk factors for lung remodelling in children with difficult to treat asthma
Source: Annual Congress 2010 - Risk factors for allergic diseases in children
Year: 2010


Are ICU patients susceptible to poor recovery outcomes including physical inactivity and heighted community falls risk? Preliminary results
Source: International Congress 2019 – Oxygen supplementation, noninvasive ventilation and mobility aspects of patients with impaired respiration
Year: 2019

Canadian incidence, prevalence and healthcare utilization for respiratory complications of adults with neuromuscular disease
Source: International Congress 2017 – Respiratory epidemiology: from sarcoidosis to respiratory infections and tuberculosis
Year: 2017


Exploring the provision of supportive care for people with severe, potentially life limiting chronic obstructive pulmonary disease in Malaysia: a qualitative study
Source: Virtual Congress 2021 – Therapies for respiratory diseases in primary care and COVID - 19
Year: 2021


Why do viral respiratory infections cause greater morbidity in children with asthma than in healthy children?
Source: Annual Congress 2012 - Viral respiratory disease in preschool children
Year: 2012


Are there special psychological features in familyes of children with different asthma severity?
Source: Eur Respir J 2003; 22: Suppl. 45, 498s
Year: 2003

Outcomes of long-term noninvasive ventilation in children and adolescents with neuromuscular disease
Source: Sleep and Breathing Conference 2017
Year: 2017

Facing the challenges of self-management in COPD: how do people adapt to the disease, its symptoms and resulting limitations?
Source: Eur Respir J 2005; 26: Suppl. 49, 310s
Year: 2005

Parenting stress related to behavioural problems and disease severity in children with problematic severe asthma
Source: International Congress 2015 – Paediatric asthma and allergy: asthma management
Year: 2015


Attenuating future risks in children with active asthma
Source: International Congress 2019 – State of the art session: Paediatric respiratory diseases
Year: 2019


A comparison of strategies to treat urban children with severe asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 315s
Year: 2003

Examining the unmet need in adults with severe asthma
Source: Eur Respir Rev 2007; 16: 67-72
Year: 2007



The burden of severe asthma in children and youths in Europe
Source: Virtual Congress 2020 – Risk factors, comorbidities and remote monitoring in childhood asthma
Year: 2020


Qualitative phenomenological study informs the development of educational intervention for behaviour change to reduce morbidity and mortality in adults with chronic lung disease in rural India
Source: Virtual Congress 2021 – Primary care organisation and epidemiology
Year: 2021


Why is ILD a different disease in children? Recognising specific diseases in chILDs
Source: International Congress 2014 – Interstitial lung disease (ILD) in children
Year: 2014